The World of Health & Medicine News

UN Agency Says 13.7 Million People Face Severe Hunger Due to Global Aid Cuts

UN Agency Says 13.7 Million People Face Severe Hunger Due to Global Aid Cuts

Almost 14 million people in Afghanistan, Democratic Republic of Congo, Haiti, Somalia, South Sudan and Sudan risk severe hunger due to cuts in global humanitarian aid, the United Nations World Food Programme (WFP) warned on Wednesday.

The WFP’s biggest donor, the United States, has slashed its foreign aid under President Donald Trump, and other major nations have also made or announced cuts in development and humanitarian assistance.

“WFP’s funding has never been more challenged. The agency expects to receive 40% less funding for 2025, resulting in a projected budget of $6.4 billion, down from $10 billion in 2024,” the Rome-based agency said.

A WFP report, titled “A Lifeline at Risk”, warned that cuts to its food assistance could push 13.7 million people from “crisis” to “emergency” levels of hunger, one step away from famine in a five-level international hunger scale.

“The gap between what WFP needs to do and what we can afford to do has never been larger. We are at risk of losing decades of progress in the fight against hunger,” WFP executive director Cindy McCain said.

“It’s not just the countries engulfed in major emergencies. Even hard-won gains in the Sahel region, where 500,000 people have been lifted out of aid dependence, could experience severe setbacks without help, and we want to prevent that,” she added.

 

spot_img

Explore more

spot_img

GSK wins US approval for twice-yearly asthma drug

GSK wins US approval for twice-yearly asthma drug  The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less...

US CDC ends guidance that all newborns should get hepatitis B...

US CDC ends guidance that all newborns should get hepatitis B vaccine, in major policy shift The U.S. Centers for Disease Control and Prevention on...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...

Women are increasingly using steroids — despite these 7 major risks

Women are increasingly using steroids — despite these 7 major risks As fitfluencers push powerlifting, weight training and “whatever it takes” to get toned, more women...

Kyverna’s cell therapy helps patients improve mobility in mid-stage trial

Kyverna's cell therapy helps patients improve mobility in mid-stage trial Kyverna Therapeutics said its experimental cell therapy met the main goal of “significantly” improving patients’...

AstraZeneca, Daiichi’s breast cancer drug gets FDA nod as first-line treatment

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment The U.S. Food and Drug ​Administration has approved ‌Daiichi Sankyo's therapy in combination ‌with...

WHO expert group’s new analysis reaffirms there is no link between...

WHO expert group’s new analysis reaffirms there is no link between vaccines and autism new analysis from a WHO global expert committee on vaccine safety...

US FDA expands use of GSK’s Blujepa as treatment for gonorrhea

US FDA expands use of GSK's Blujepa as treatment for gonorrhea The U.S. Food and Drug Administration said on Thursday it has expanded the use...